Chapter/Section Purchase

1 Study Coverage
1.1 Oral Anticoagulants Product Introduction
1.2 Global Oral Anticoagulants Outlook 2017 VS 2022 VS 2028
1.2.1 Global Oral Anticoagulants Sales in US$ Million for the Year 2017-2028
1.2.2 Global Oral Anticoagulants Sales in Volume for the Year 2017-2028
1.3 United States Oral Anticoagulants Outlook 2017 VS 2022 VS 2028
1.3.1 United States Oral Anticoagulants Sales in US$ Million for the Year 2017-2028
1.3.2 United States Oral Anticoagulants Sales in Volume for the Year 2017-2028
1.4 Oral Anticoagulants Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Oral Anticoagulants in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Oral Anticoagulants Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Oral Anticoagulants Market Dynamics
1.5.1 Oral Anticoagulants Industry Trends
1.5.2 Oral Anticoagulants Market Drivers
1.5.3 Oral Anticoagulants Market Challenges
1.5.4 Oral Anticoagulants Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Oral Anticoagulants Market Segment by Type
2.1.1 Direct Thrombin Inhibitors
2.1.2 Direct Factor Xa Inhibitors
2.2 Global Oral Anticoagulants Market Size by Type
2.2.1 Global Oral Anticoagulants Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Oral Anticoagulants Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Oral Anticoagulants Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Oral Anticoagulants Market Size by Type
2.3.1 United States Oral Anticoagulants Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Oral Anticoagulants Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Oral Anticoagulants Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Oral Anticoagulants Market Segment by Application
3.1.1 Deep Vein Thrombosis (DVT)
3.1.2 Pulmonary Embolism
3.1.3 Acute Coronary Syndrome
3.1.4 Hemodialysis
3.1.5 Others
3.2 Global Oral Anticoagulants Market Size by Application
3.2.1 Global Oral Anticoagulants Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Oral Anticoagulants Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Oral Anticoagulants Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Oral Anticoagulants Market Size by Application
3.3.1 United States Oral Anticoagulants Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Oral Anticoagulants Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Oral Anticoagulants Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Oral Anticoagulants Competitor Landscape by Company
4.1 Global Oral Anticoagulants Market Size by Company
4.1.1 Top Global Oral Anticoagulants Manufacturers Ranked by Revenue (2021)
4.1.2 Global Oral Anticoagulants Revenue by Manufacturer (2017-2022)
4.1.3 Global Oral Anticoagulants Sales by Manufacturer (2017-2022)
4.1.4 Global Oral Anticoagulants Price by Manufacturer (2017-2022)
4.2 Global Oral Anticoagulants Concentration Ratio (CR)
4.2.1 Oral Anticoagulants Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Oral Anticoagulants in 2021
4.2.3 Global Oral Anticoagulants Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Oral Anticoagulants Manufacturing Base Distribution, Product Type
4.3.1 Global Oral Anticoagulants Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Oral Anticoagulants Product Type
4.3.3 Date of International Manufacturers Enter into Oral Anticoagulants Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Oral Anticoagulants Market Size by Company
4.5.1 Top Oral Anticoagulants Players in United States, Ranked by Revenue (2021)
4.5.2 United States Oral Anticoagulants Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Oral Anticoagulants Sales by Players (2020, 2021 & 2022)
5 Global Oral Anticoagulants Market Size by Region
5.1 Global Oral Anticoagulants Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Oral Anticoagulants Market Size in Volume by Region (2017-2028)
5.2.1 Global Oral Anticoagulants Sales in Volume by Region: 2017-2022
5.2.2 Global Oral Anticoagulants Sales in Volume Forecast by Region (2023-2028)
5.3 Global Oral Anticoagulants Market Size in Value by Region (2017-2028)
5.3.1 Global Oral Anticoagulants Sales in Value by Region: 2017-2022
5.3.2 Global Oral Anticoagulants Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Oral Anticoagulants Market Size YoY Growth 2017-2028
6.1.2 North America Oral Anticoagulants Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Oral Anticoagulants Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Oral Anticoagulants Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Oral Anticoagulants Market Size YoY Growth 2017-2028
6.3.2 Europe Oral Anticoagulants Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Oral Anticoagulants Market Size YoY Growth 2017-2028
6.4.2 Latin America Oral Anticoagulants Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Oral Anticoagulants Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Oral Anticoagulants Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Corporation Information
7.1.2 Johnson & Johnson Description and Business Overview
7.1.3 Johnson & Johnson Oral Anticoagulants Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Johnson & Johnson Oral Anticoagulants Products Offered
7.1.5 Johnson & Johnson Recent Development
7.2 Bristol-Myers Squibb
7.2.1 Bristol-Myers Squibb Corporation Information
7.2.2 Bristol-Myers Squibb Description and Business Overview
7.2.3 Bristol-Myers Squibb Oral Anticoagulants Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Bristol-Myers Squibb Oral Anticoagulants Products Offered
7.2.5 Bristol-Myers Squibb Recent Development
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Corporation Information
7.3.2 Boehringer Ingelheim Description and Business Overview
7.3.3 Boehringer Ingelheim Oral Anticoagulants Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Boehringer Ingelheim Oral Anticoagulants Products Offered
7.3.5 Boehringer Ingelheim Recent Development
7.4 Sanofi
7.4.1 Sanofi Corporation Information
7.4.2 Sanofi Description and Business Overview
7.4.3 Sanofi Oral Anticoagulants Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Sanofi Oral Anticoagulants Products Offered
7.4.5 Sanofi Recent Development
7.5 Daiichi Sankyo
7.5.1 Daiichi Sankyo Corporation Information
7.5.2 Daiichi Sankyo Description and Business Overview
7.5.3 Daiichi Sankyo Oral Anticoagulants Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Daiichi Sankyo Oral Anticoagulants Products Offered
7.5.5 Daiichi Sankyo Recent Development
7.6 Armatheon
7.6.1 Armatheon Corporation Information
7.6.2 Armatheon Description and Business Overview
7.6.3 Armatheon Oral Anticoagulants Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Armatheon Oral Anticoagulants Products Offered
7.6.5 Armatheon Recent Development
7.7 Aspen
7.7.1 Aspen Corporation Information
7.7.2 Aspen Description and Business Overview
7.7.3 Aspen Oral Anticoagulants Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Aspen Oral Anticoagulants Products Offered
7.7.5 Aspen Recent Development
7.8 AstraZeneca
7.8.1 AstraZeneca Corporation Information
7.8.2 AstraZeneca Description and Business Overview
7.8.3 AstraZeneca Oral Anticoagulants Sales, Revenue and Gross Margin (2017-2022)
7.8.4 AstraZeneca Oral Anticoagulants Products Offered
7.8.5 AstraZeneca Recent Development
7.9 Bayer
7.9.1 Bayer Corporation Information
7.9.2 Bayer Description and Business Overview
7.9.3 Bayer Oral Anticoagulants Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Bayer Oral Anticoagulants Products Offered
7.9.5 Bayer Recent Development
7.10 Cellceutix
7.10.1 Cellceutix Corporation Information
7.10.2 Cellceutix Description and Business Overview
7.10.3 Cellceutix Oral Anticoagulants Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Cellceutix Oral Anticoagulants Products Offered
7.10.5 Cellceutix Recent Development
7.11 Cosmo Pharmaceuticals
7.11.1 Cosmo Pharmaceuticals Corporation Information
7.11.2 Cosmo Pharmaceuticals Description and Business Overview
7.11.3 Cosmo Pharmaceuticals Oral Anticoagulants Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Cosmo Pharmaceuticals Oral Anticoagulants Products Offered
7.11.5 Cosmo Pharmaceuticals Recent Development
7.12 CSL Behring
7.12.1 CSL Behring Corporation Information
7.12.2 CSL Behring Description and Business Overview
7.12.3 CSL Behring Oral Anticoagulants Sales, Revenue and Gross Margin (2017-2022)
7.12.4 CSL Behring Products Offered
7.12.5 CSL Behring Recent Development
7.13 Eisai
7.13.1 Eisai Corporation Information
7.13.2 Eisai Description and Business Overview
7.13.3 Eisai Oral Anticoagulants Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Eisai Products Offered
7.13.5 Eisai Recent Development
7.14 GSK
7.14.1 GSK Corporation Information
7.14.2 GSK Description and Business Overview
7.14.3 GSK Oral Anticoagulants Sales, Revenue and Gross Margin (2017-2022)
7.14.4 GSK Products Offered
7.14.5 GSK Recent Development
7.15 Marathon Pharmaceuticals
7.15.1 Marathon Pharmaceuticals Corporation Information
7.15.2 Marathon Pharmaceuticals Description and Business Overview
7.15.3 Marathon Pharmaceuticals Oral Anticoagulants Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Marathon Pharmaceuticals Products Offered
7.15.5 Marathon Pharmaceuticals Recent Development
7.16 Ockham Biotech
7.16.1 Ockham Biotech Corporation Information
7.16.2 Ockham Biotech Description and Business Overview
7.16.3 Ockham Biotech Oral Anticoagulants Sales, Revenue and Gross Margin (2017-2022)
7.16.4 Ockham Biotech Products Offered
7.16.5 Ockham Biotech Recent Development
7.17 Perosphere
7.17.1 Perosphere Corporation Information
7.17.2 Perosphere Description and Business Overview
7.17.3 Perosphere Oral Anticoagulants Sales, Revenue and Gross Margin (2017-2022)
7.17.4 Perosphere Products Offered
7.17.5 Perosphere Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Oral Anticoagulants Industry Chain Analysis
8.2 Oral Anticoagulants Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Oral Anticoagulants Distributors
8.3 Oral Anticoagulants Production Mode & Process
8.4 Oral Anticoagulants Sales and Marketing
8.4.1 Oral Anticoagulants Sales Channels
8.4.2 Oral Anticoagulants Distributors
8.5 Oral Anticoagulants Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer